Limited small cell lung cancer: Prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation Journal Article


Authors: Armstrong, J. G.; Rosenstein, M. M.; Scher, H. I.; Fass, D. E.; Zelefsky, M. J.; Kris, M. G.
Article Title: Limited small cell lung cancer: Prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation
Abstract: Limited-stage small cell lung cancer is frequently treated with induction combination chemotherapy (ICC), followed by consolidation with thoracic irradiation. It has been suggested that patients who do not have a complete response to ICC are unlikely to have control of occult distant metastasis and consequently have such a poor prognosis that thoracic irradiation is unlikely to be of benefit. To examine this hypothesis, 48 patients treated on prospective protocols who achieved a complete response to ICC or subsequently to thoracic irradiation were analyzed. Twenty-four patients had a complete response to ICC (CR-ICC), and 24 subsequently converted to complete-response status after thoracic irradiation (CR-TI). The two groups had similar prognostic factors and treatment. Comparing CR-ICC and CR-TI patients, survival was 40% versus 26% at 2 years and 35% versus 4% at 5 years, respectively (P < .05). Freedom from distant metastasis was 41% at 5 years for the CR-ICC patients and 8% for the CR-TI patients (P < .05). A modest number of CR-TI patients were long-term survivors, suggesting a value for thoracic irradiation as consolidation therapy.
Keywords: adult; cancer chemotherapy; clinical article; aged; cisplatin; doxorubicin; treatment planning; conference paper; cancer radiotherapy; comparative study; combined modality therapy; etoposide; antineoplastic combined chemotherapy protocols; lung neoplasms; cyclophosphamide; vincristine; lung small cell cancer; radiotherapy, high-energy; intravenous drug administration; carcinoma, small cell; middle age; prognosis; human; male; female; priority journal; lung neoplasms, therapeutic radiology, 60.321; lung neoplasms, therapy, 60.321
Journal Title: Radiology
Volume: 178
Issue: 3
ISSN: 0033-8419
Publisher: Radiological Society of North America, Inc.  
Date Published: 1991-03-01
Start Page: 875
End Page: 878
Language: English
DOI: 10.1148/radiology.178.3.1847240
PUBMED: 1847240
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    754 Zelefsky
  2. Howard Scher
    1130 Scher
  3. Mark Kris
    869 Kris
  4. Daniel E. Fass
    29 Fass